The neuroprotective effects of phosphocreatine on Amyloid Beta 25–35-induced differentiated neuronal cell death through inhibition of AKT /GSK-3β /Tau/APP /CDK5 pathways in vivo and vitro

Jie Ai,Hongyan Wang,Peng Chu,Abdullah Shopit,Mengyue Niu,Nisar Ahmad,Tsehaye Tesfaldet,Fu Han Wang,Jia Ni Fang,Xiaodong Li,Shi Jie Tang,Qing Ju Han,Guozhu Han,Jinyong Peng,Zeyao Tang
DOI: https://doi.org/10.1016/j.freeradbiomed.2020.10.003
IF: 8.101
2021-01-01
Free Radical Biology and Medicine
Abstract:Alzheimer (AD) is a degenerative disease that can lead memory loss and behavioral dysfunction. Aβ protein and phosphorylation of Tau protein are related to the onset of AD. However, at present, its treatment and drugs are limited. The purpose of our study is to evaluate whether phosphocreatine (PCr) could protect neuronal injury induced by Aβ protein in vivo and in vitro through AKT/GSK-3β/Tau/APP/CDK5 pathways. Differentiated PC-12 cells were cultured with Aβ25-35 for 24 h, while the mice were injected with D-Galactose for eight weeks, both of them were pretreated with PCr for 2 h. The results showed PCr could obviously induce cells and hippocampus apoptosis using DAPI and TUNEL. PCr decreased the levels of intercellular reactive oxygen species (ROS) and malondialdehyde (MDA), and increased the activities of superoxide dismutase (SOD). Besides, the apoptosis pathway was detected using Western blot, showing that PCr could significantly reduce caspase-3, caspase-9, Bcl-2/Bax expression in vivo and in vitro. At the same time, PCr could decreased Ca<sup>2+</sup> and apoptosis by Flow Cytometry in PC-12 cells. We observed that the morphological alteration of hippocampus injury was mitigated with the pretreatment of PCr. Furthermore, PCr pretreatment could decrease Aβ25-35-induced PC-12 cells apoptosis with APP cDNA transfection, which up-regulated AKT/GSK-3β/CDK5 pathways and induced Tau phosphorylation. In summary, PCr could reduce Aβ25-35 toxicity to protect neuronal cells via AKT/GSK-3β/CDK5 pathways.
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether phosphocreatine (PCr) can protect neuron cell death induced by Aβ25 - 35 by inhibiting the AKT/GSK - 3β/Tau/APP/CDK5 signaling pathway, thereby providing potential treatment strategies for Alzheimer's disease (AD). ### Specific problems and research background: 1. **Pathological mechanism of Alzheimer's disease (AD)**: - AD is a neurodegenerative disease, whose characteristics include memory loss, behavioral dysfunction, etc. - The excessive phosphorylation of Aβ protein (Amyloid Beta) and Tau protein is closely related to the occurrence of AD. - Currently, the treatment methods and drug options for AD are limited, and there is an urgent need to find new treatment targets and strategies. 2. **The role of Aβ25 - 35**: - Aβ25 - 35 is a fragment of Aβ protein, which can induce neuronal cell apoptosis and lead to oxidative stress and mitochondrial dysfunction. - Excessive Aβ25 - 35 will trigger excessive reactive oxygen species (ROS), which will further damage DNA, RNA, proteins and polyunsaturated fatty acids, and ultimately affect neuronal function. 3. **The role of phosphocreatine (PCr)**: - PCr is a high - energy phosphate compound, which is widely used in the adjuvant treatment of certain diseases and as a sports nutrition supplement. - Previous studies have shown that PCr can relieve vascular endothelial damage complicated by diabetes and has the potential to treat ischemic diseases. - However, the role of PCr in neuroprotection and its potential mechanism are still unclear. ### Research purposes: This study aims to evaluate whether PCr can reduce neuron cell damage induced by Aβ25 - 35 by inhibiting the AKT/GSK - 3β/Tau/APP/CDK5 signaling pathway. Specifically, the study is explored through the following aspects: - **In vitro experiments**: Use the differentiated PC - 12 cell line to observe the effects of PCr on cell apoptosis, ROS generation, mitochondrial membrane potential changes and calcium ion levels induced by Aβ25 - 35. - **In vivo experiments**: Establish a mouse model by injecting D - galactose to observe the protective effect of PCr on neuron damage in the hippocampus. - **Molecular mechanism**: Detect the effects of PCr on the expression of key proteins such as AKT, GSK - 3β, Tau, APP and CDK5 to reveal its potential molecular mechanism. ### Summary: The core problem of this paper is to verify whether PCr can protect neuron cells from damage induced by Aβ25 - 35 by regulating specific signaling pathways, thereby providing new ideas and methods for the treatment of AD.